Company intelligence / Profile preview

Simple Touch

Ownership: Private
Development stage: Commercial

Overview

Simple Touch is a rapidly growing surgical robotics company based in Shanghai. Founded around 2019, it has developed a tumor puncture surgical robot and other products that are advancing toward regulatory approval in China. The company completed two rounds of financing within half a year in 2022—including an A+ round led by Walden International—raising over $10 million to support NMPA registration applications, market development, brand building, and continued R&D of its multi-product pipeline.

Therapeutic areas: Oncology
Modalities: DeviceSurgical robot (robotic-assisted surgery)
Industry: Surgical Medical Devices

Partnerships

Walden International (lead investor)Creekwood Investment (financial adviser)

Beyond the preview

Go deeper on Simple Touch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Simple Touch.

Explore the full profile